184 related articles for article (PubMed ID: 36372347)
1. Characteristics that Correlate with Macular Atrophy in Ranibizumab-Treated Patients with Neovascular Age-Related Macular Degeneration.
Staurenghi G; Cozzi M; Sadda S; Hill L; Gune S
Ophthalmol Retina; 2023 Apr; 7(4):300-306. PubMed ID: 36372347
[TBL] [Abstract][Full Text] [Related]
2. Spectral-Domain OCT Analysis of Risk Factors for Macular Atrophy Development in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
Sadda SR; Abdelfattah NS; Lei J; Shi Y; Marion KM; Morgenthien E; Gune S; Balasubramanian S
Ophthalmology; 2020 Oct; 127(10):1360-1370. PubMed ID: 32402555
[TBL] [Abstract][Full Text] [Related]
3. Spectral-Domain OCT-Based Prevalence and Progression of Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
Gune S; Abdelfattah NS; Karamat A; Balasubramanian S; Marion KM; Morgenthien E; Sadda SR
Ophthalmology; 2020 Apr; 127(4):523-532. PubMed ID: 31718842
[TBL] [Abstract][Full Text] [Related]
4. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
Sadda SR; Tuomi LL; Ding B; Fung AE; Hopkins JJ
Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692
[TBL] [Abstract][Full Text] [Related]
5. OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study.
Nassisi M; Lei J; Abdelfattah NS; Karamat A; Balasubramanian S; Fan W; Uji A; Marion KM; Baker K; Huang X; Morgenthien E; Sadda SR
Ophthalmology; 2019 Dec; 126(12):1667-1674. PubMed ID: 31281056
[TBL] [Abstract][Full Text] [Related]
6. Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR.
Freund KB; Staurenghi G; Jung JJ; Zweifel SA; Cozzi M; Hill L; Blotner S; Tsuboi M; Gune S
Graefes Arch Clin Exp Ophthalmol; 2022 Aug; 260(8):2437-2447. PubMed ID: 35239009
[TBL] [Abstract][Full Text] [Related]
7. Are Dilated Fundus Examinations Needed for OCT-Guided Retreatment of Exudative Age-Related Macular Degeneration?
Patel Y; Miller DM; Fung AE; Hill LF; Rosenfeld PJ
Ophthalmol Retina; 2020 Feb; 4(2):141-147. PubMed ID: 31735634
[TBL] [Abstract][Full Text] [Related]
8. Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial.
Abdelfattah NS; Al-Sheikh M; Pitetta S; Mousa A; Sadda SR; Wykoff CC;
Ophthalmology; 2017 Feb; 124(2):215-223. PubMed ID: 27863845
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Macular Atrophy in the MARINA Study of Ranibizumab versus Sham for Neovascular Age-Related Macular Degeneration.
Blodi BA; Domalpally A; Corkery E; Osborne A; Blotner S; Grzeschik SM; Gune S
Ophthalmol Retina; 2023 Aug; 7(8):661-671. PubMed ID: 37086257
[TBL] [Abstract][Full Text] [Related]
10. Intralesional Macular Atrophy in Anti-Vascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration in the IVAN Trial.
Bailey C; Scott LJ; Rogers CA; Reeves BC; Hamill B; Peto T; Chakravarthy U; Harding SP;
Ophthalmology; 2019 Jan; 126(1):75-86. PubMed ID: 30301555
[TBL] [Abstract][Full Text] [Related]
11. Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial.
Abdelfattah NS; Hariri AH; Al-Sheikh M; Pitetta S; Ebraheem A; Wykoff CC; Sadda SR;
Am J Ophthalmol; 2018 Aug; 192():84-90. PubMed ID: 29763612
[TBL] [Abstract][Full Text] [Related]
12. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
13. Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registry.
Sánchez-Monroy J; Nguyen V; Puzo M; Calvo P; Arruabarrena C; Monaco P; Chilov M; Keegan D; Barthelmes D; Gillies M
Acta Ophthalmol; 2023 Jun; 101(4):457-464. PubMed ID: 36536538
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and characteristics of macular atrophy in eyes with neovascular age-related macular degeneration. A study from a long-term observational dataset: the Fight Retinal Blindness! project.
Daien V; Nguyen V; Essex RW; Guymer R; Arnold JJ; Munk M; Ceklic L; Gillies MC; Barthelmes D;
Br J Ophthalmol; 2020 Aug; 104(8):1064-1069. PubMed ID: 31843790
[TBL] [Abstract][Full Text] [Related]
15. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.
Jaffe GJ; Martin DF; Toth CA; Daniel E; Maguire MG; Ying GS; Grunwald JE; Huang J;
Ophthalmology; 2013 Sep; 120(9):1860-70. PubMed ID: 23642377
[TBL] [Abstract][Full Text] [Related]
16. Subretinal Fluid Resolution and Visual Acuity in Patients with Neovascular Age-Related Macular Degeneration: A HARBOR Post Hoc Analysis.
Lally DR; Hill L; Amador-Patarroyo MJ
Ophthalmol Retina; 2022 Nov; 6(11):1054-1060. PubMed ID: 35654363
[TBL] [Abstract][Full Text] [Related]
17. Hyperreflective Material Boundary Remodeling in Neovascular Age-Related Macular Degeneration: A Post Hoc Analysis of the AVENUE Trial.
Yu S; Bachmeier I; Hernandez-Sanchez J; Garcia Armendariz B; Ebneter A; Pauleikhoff D; Chakravarthy U; Fauser S
Ophthalmol Retina; 2023 Nov; 7(11):990-998. PubMed ID: 37422192
[TBL] [Abstract][Full Text] [Related]
18. Macular Atrophy Incidence and Progression in Eyes with Neovascular Age-Related Macular Degeneration Treated with Vascular Endothelial Growth Factor Inhibitors Using a Treat-and-Extend or a Pro Re Nata Regimen: Four-Year Results of the MANEX Study.
Spooner KL; Fraser-Bell S; Cozzi M; Staurenghi G; Invernizzi A; Monteduro D; Munk MR; Hong T; Chang AA
Ophthalmology; 2020 Dec; 127(12):1663-1673. PubMed ID: 32544561
[TBL] [Abstract][Full Text] [Related]
19. Anti-VEGF-resistant subretinal fluid is associated with better vision and reduced risk of macular atrophy.
Zarbin MA; Hill L; Maunz A; Gliem M; Stoilov I
Br J Ophthalmol; 2022 Nov; 106(11):1561-1566. PubMed ID: 34039560
[TBL] [Abstract][Full Text] [Related]
20. Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial Comparing Ranibizumab and Aflibercept (RIVAL Study).
Gillies MC; Hunyor AP; Arnold JJ; Guymer RH; Wolf S; Pecheur FL; Munk MR; McAllister IL
Ophthalmology; 2020 Feb; 127(2):198-210. PubMed ID: 31619357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
